Ipca Laboratories Ltd.

NSE: IPCALAB | BSE: 524494 | ISIN: INE571A01038 | Industry: Pharmaceuticals
| Mid-range Performer

1465.90
-0.41%
Motilal Oswal
After three years of earnings deterioration, IPCA is well-poised to deliver strong earnings growth over FY24-27.
Ipca Laboratories Ltd. has an average target of 1595.00 from 3 brokers.
More from Ipca Laboratories Ltd.
Recommended